Blog

In the face of the challenges of the ultra-elderly society and the shortage of medical staff, the traditional single-outpatient primary care model is unsustainable. With the advancement of science and technology, continuous health management has become an important topic in modern medical care. In order to improve the health level of the whole population, the government has launched the Mega Doctor Programme, which emphasizes prevention first, advocates a personalized and continuous health management model, and aims to reduce the occurrence and exacerbation of chronic diseases, especially cardiovascular diseases, diabetes and hypertension.

In today’s complex healthcare environment, effective out-of-pocket financial communication has become a key challenge for physicians. As healthcare costs continue to rise and payment models evolve, physicians increasingly need to have financial discussions with patients. However, many physicians find themselves ill-equipped to handle these sensitive conversations, leading to potential misunderstandings, patient dissatisfaction, and even compromise the quality of care.

At present, there are at least 100 special medication patient support programs in the Taiwan market, which are provided by licensed pharmaceutical companies to medical units and patients to help patients continue treatment through the use of the plan in a way that is suitable for the purpose of the plan. At present, there are many types of patient drug support programs on the market, which are used to purchase drugs at their own expense and are used as free drugs, and patients join the drug free support program (hereinafter referred to as the drug free program) to reduce their financial burden.

Proactive patient financial assistance programs can help alleviate the financial distress of cancer patients, especially those living in high and medium-high social vulnerability index counties. Expertise with third-party partners mitigates financial toxicity for patients in the short term and helps drive more equitable cancer outcomes.

With the development of science and technology, health management is no longer the preserve of medical professionals, but a part of daily life that everyone can master. With its precise health data and powerful features, Garmin smartwatches have become the best companion for many people to monitor their health. Take you through the day and learn how to understand and apply the health data provided by Garmin to protect your health.

Raising awareness of diseases through art exhibitions has become an important trend in modern health education. With its unique visual and emotional expression, art has the ability to touch people’s hearts and transcend the limitations of words and cold data. Art exhibitions not only attract a wide audience, but also stimulate public interest and sympathy for the disease, thereby driving more social attention and resource investment. The “Beyond the Diagnosis” art exhibition exemplifies this trend, opening a window into the world of rare diseases, not only improving education, but also speeding up the diagnosis of this once-invisible community.

In today’s fast-paced healthcare industry, patient service programs are being transformed, all driven by cutting-edge technology. From improving patient compliance and drug affordability to improving patient access and advocacy, the use of technology is reshaping traditional healthcare models to make them more personalized and efficient.

In today’s era of medical data explosion, the reporting of adverse events (AEs) both poses a challenge to drug safety assessment and drives advances in drug safety. According to the latest research by Jeremy Jokinen’s team, data sources such as patient support programs (PSPs/PAPs), market research programs (MRPs) and social media are of great value for the collection and statistics of drug safety data. The study found that the drug safety data provided by PSPs is more valuable and usable than other sources.

PatientsForce’s digital management platform service for PatientsForce was today awarded the SME Award in the Social Innovation Category of the 20th Global ESG Corporate Sustainability Awards, in recognition of the company’s impact value in social innovation. The PatientsForce Patient Support Program focuses on providing patient support programs for self-financed new drugs, reducing the financial burden on patients, providing patient-centered companion care, and case management through a digital management platform, serving tens of thousands of cancer and specialty medication patients every year.

According to the Asia Mental Health Index 2023, 82% of employees in Asia have a high to moderate mental health risk, which not only affects the quality of life of the individual, but also may lead to a decline in workplace productivity. In fact, mental health problems such as depression, anxiety and stress not only threaten our psychological state, but are also significantly associated with the risk of cardiovascular disease.

Incyte’s JAK inhibitor ointment Opzelura performed well in the treatment of moderate to severe hidradenitis suppurativa (HS).

Founded in 2020 by U.S. investment firm Perceptive Advisors, LianBio (LianBio) is developing and commercializing investigational drugs in the U.S. or Europe by introducing and licensing drugs in the United States or Europe. “Our vision is to be the gateway for Western biopharmaceutical companies to China,” the company wrote in its IPO filing.